Novel effective solution to prevent & treat severe wounds

Our key assets are integral to our ability to develop, produce, and commercialize innovative wound care solutions. These assets are:Teknopark Istanbul (Accredited Internationally, State of the art EU Labs, CFO and Legal Support): Umayana operates out of Teknopark Istanbul, a leading technology accelerator center. This location provides Umayana with modern office spaces and access to research and development facilities that are essential for conducting its biotechnological research.

The Teknopark facilities offer financial administration, legal support, and a collaborative environment, enabling Umayana to conduct cutting-edge R&D and scale its operations efficiently.

Production Facilities:.We get access to high-quality manufacturing processes, certified by ISO standards, which ensures that Murnia can be produced consistently at a level that meets global regulatory requirements.

R&D and Laboratory Expertise: Umayana has access to advanced laboratory setups for testing and developing our novel formulations. These labs are crucial for conducting pilot studies, particularly in collaboration with Istanbul Aydin University Medical Park Hospital, **Yeditepe University (Department of Medical Device R&D),Medicana International Istanbul Hospital (Department of Radiation Oncology)**1 and other research institutions.

In-house R&D expertise ensures the continuous development of Murnia, enabling us to adapt our solutions to evolving patient needs and regulatory requirements.

Global Patents and Intellectual Property Portfolio: We hold global patents for our proprietary formulations, including US11331360B2 and WO2020072987A1, covering the innovative wound healing compounds that underpin Murnia. These patents protect Umayana’s intellectual property and provide a competitive advantage in the wound care market by preventing competitors from replicating its technology.

These assets collectively enable Umayana to innovate, scale production, and effectively enter global markets, positioning the company as a leader in the wound care and biotech industry.